Bacterial Vaginosis. Vaginitis, vulvitis and vulvovaginitis in infectious and parasitic diseases classified elsewhere
Conditions
Interventions
Intervention 1: Intervention group:Phytovagex vaginal suppository, a suppository every night for seven nights. Intervention 2: Control group: oral metronidazole 250 mg tablets, two tablets every 12 ho
Treatment - Drugs
Placebo
Intervention group:Phytovagex vaginal suppository, a suppository every night for seven nights
Control group: oral metronidazole 250 mg tablets, two tablets every 12 hours for seven nights
Control group:placebo suppository every night for seven nights a vaginal suppository
Intervention group: placebo oral tablet 2 tablets every 12 hours for seven nights
Sponsors
Mashhad University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
15 Years to 49 Years
Inclusion criteria
Inclusion criteria: (Inclusion criteria:married;the age range between 30-18 years;no pregnant; IUD is not;during breastfeeding is not;Failure to perform hysterosalpangiography ,curettage and surgery of uterine in the past two weeks;absence of a history of sensitivity to oral metronidazole;broad-spectrum antibiotics and the immune system depressant drugs the past two weeks;lack of use of alcohol and anticoagulant drugs;absence of problems and anomalies of the cervix;the absence of pelvic inflammatory disease;the Absence of abnormal uterine bleeding (AUB or DUB) Exclusion criteria: Sensitivity to prescribed drug; take antibiotics (injectable, oral or vaginal) during the intervention; not using drug more than one time)
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Amsel criteria. Timepoint: 7-10 days after treatment. Method of measurement: Three Amsel criteria (homogeneous gray discharge, positive Whiff test 5.4PH=). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMahin kiyani mesk
Mashhad University of Medical Sciences
Outcome results
None listed